Author

Runyu Wang

Shanghai Jiao Tong UniversityPrimary ORCID profile (0009-0000-4722-9433 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Runyu WangiD1 paper · Boston University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anhui Wang· 1 shared Bo SuniD· 1 shared Chenqi XuiD· 1 shared Dinglin ZhangiD· 1 shared Fei ShaoiD· 1 shared Guohui LiiD· 1 shared Huairui Yuan· 1 shared Junshuang Liu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anhui Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Catch-bond engineering surpasses high-affinity maturation for T cell receptor therapies against solid tumors

Tianqi Huang, Runyu Wang, Dinglin Zhang, Siqi Wu, Yuanhao Wang, Yuanhao Wang, Zhengxu Ren, Sifan Wang, Lan Li, Yan Zhou, Xiaojing Wang, Yanling Bao, Mingyu Fan, Luxue Zhang, Junshuang Liu, , Xiang Zhao

This study shows that catch-bond engineering improves TCR-T cell therapy efficacy against solid tumors without off-target toxicity, surpassing traditional high-affinity maturation strategies.

bioRxiv · Jul 29, 2026 · PreprintImmunology